Synthesis and structure–activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents
摘要:
The synthesis and study of the structure-activity relationships of cytotoxic compounds based on N-pyridinyl or N-aryl-2-(1-benzylindol-3-yl)glyoxamide skeleton, represented by the lead structures D-24241 and D-24851, are described. The presence of N-(pyridin-4-yl) moiety was crucial for activity and 2-[1(4-chloro-3-nitrobenzyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-4-yl) acetamide (55), the most potent derivative, showed IC(50) = 39 nM, 51 nM and 11 nM against HeLa/KB (human cervix carcinoma), L1210 (murine leukemia) and SKOV3 (human ovarian carcinoma) cell lines proliferation assay, respectively, as active as the lead compounds. (C) 2009 Elsevier Ltd. All rights reserved.
2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
申请人:——
公开号:US20040029858A1
公开(公告)日:2004-02-12
2-(III-Indol-3-yl)-2-oxo-acetamide derivatives of formula (I) having antitumor activity in particular against solid tumors, specifically colon and lung tumors.
1
2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY
申请人:Novuspharma S.p.A.
公开号:EP1322646A1
公开(公告)日:2003-07-02
US6987122B2
申请人:——
公开号:US6987122B2
公开(公告)日:2006-01-17
[EN] 2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY<br/>[FR] AMIDES D'ACIDE ACETIQUE 2-(1H-INDOL-3-YL)-2-OXO A ACTIVITE ANTITUMORALE
申请人:NOVUSPHARMA SPA
公开号:WO2002008225A1
公开(公告)日:2002-01-31
2-(1H-Indol-3-yl)-2-oxo-acetamide derivatives of formula (I) having antitumor activity in particular against solid tumors, specifically colon and lung tumors.